This recorded webinar examines ethical considerations in allocating scarce medications, like Remdesivir, during the current pandemic. These include the ethical foundation for giving slightly greater priority to essential workers and the ethical foundation for an “affirmative action” approach that gives slightly greater priority to those from disadvantaged groups. In a conversation with Lisa Parker, PhD, Director of the University of Pittsburgh Center for Bioethics and Health Law, Mark Schmidhofer, MD, MS, Director of the Coronary Intensive Care Unit at UPMC Presbyterian Hospital discusses these issues.
**Instructions to access the recording will be provided after you register.**
Target Audience
This presentation is appropriate for public health and clinical professionals, attorneys, researchers, students, and others interested in learning more about pandemic preparedness.
Facilitator
Lisa S. Parker, PhD, is Dickie, McCamey, and Chilcote Professor of Bioethics and Director of the University of Pittsburgh Center for Bioethics & Law. She collaborates with investigators across the University, as well as national and international colleagues, on both empirical studies and theoretical and policy analyses of bioethical issues, particularly in genomic medicine and research. Parker has served on panels and working groups for the NHGRI and projects with the NIMH, NIDA, and NICHD. At the state level, she has consulted on newborn screening (Pennsylvania) and stem cell research (Maryland). For the University of Pittsburgh, she provides ethics consultation to the Institute for Precision Medicine and Office of Research through the Research, Ethics and Society Initiative, which she directs.
Instructor
Mark Schmidhofer, MD, MS is a Professor of Medicine and the Director of the Coronary Intensive Care Unit at the UPMC Presbyterian Hospital. He also serves as the Associate Director of the UPMC/University of Pittsburgh Cardiology Fellowship training program, and won the Outstanding Teaching Award from the Cardiology Fellows. Based on his research of critical care cardiology and nuclear cardiology, Schmidhofer published on topics ranging from the use of vasopressors and inotropes in intensive care units, to ambiguity and workarounds as contributors to medical errors. Most relevant to this program’s topic, Schmidhofer serves as Chair of the UPMC-Presbyterian Pharmacy and Therapeutics Committee and is Director of the UPMC Pharmacy Service Line.
Technology Requirements
This recorded webinar is presented through the Vimeo Internet-based platform. A computer with high-speed internet connection and the ability to download and run this platform is required.
Creation Date
This training was recorded July 7, 2020.
For more information about this course or assistance with registration, contact us at marphtc@pitt.edu.